Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 49% ± 21% | |
astrocyte | 5 studies | 38% ± 17% | |
GABAergic neuron | 4 studies | 25% ± 7% | |
glutamatergic neuron | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1166.82 | 2639 / 2642 | 97% | 19.52 | 682 / 705 |
adrenal gland | 99% | 2123.44 | 256 / 258 | 83% | 13.08 | 190 / 230 |
thymus | 98% | 864.89 | 641 / 653 | 82% | 26.90 | 495 / 605 |
skin | 67% | 571.55 | 1209 / 1809 | 91% | 37.10 | 428 / 472 |
pancreas | 89% | 343.49 | 293 / 328 | 37% | 2.07 | 66 / 178 |
kidney | 96% | 626.00 | 85 / 89 | 22% | 2.30 | 196 / 901 |
lung | 75% | 292.29 | 432 / 578 | 39% | 4.98 | 453 / 1155 |
ovary | 98% | 525.04 | 177 / 180 | 10% | 0.49 | 44 / 430 |
bladder | 81% | 383.90 | 17 / 21 | 26% | 2.29 | 133 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.86 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 56.42 | 79 / 80 |
blood vessel | 90% | 625.51 | 1208 / 1335 | 0% | 0 | 0 / 0 |
breast | 78% | 312.83 | 358 / 459 | 3% | 0.15 | 30 / 1118 |
prostate | 71% | 246.51 | 173 / 245 | 2% | 0.11 | 12 / 502 |
intestine | 68% | 368.84 | 660 / 966 | 3% | 0.14 | 16 / 527 |
adipose | 65% | 251.39 | 784 / 1204 | 0% | 0 | 0 / 0 |
stomach | 61% | 190.84 | 219 / 359 | 1% | 0.08 | 4 / 286 |
esophagus | 55% | 213.17 | 794 / 1445 | 1% | 0.05 | 2 / 183 |
uterus | 39% | 102.73 | 66 / 170 | 8% | 0.61 | 36 / 459 |
heart | 30% | 82.67 | 254 / 861 | 0% | 0 | 0 / 0 |
spleen | 10% | 20.24 | 23 / 241 | 0% | 0 | 0 / 0 |
liver | 1% | 1.60 | 2 / 226 | 2% | 0.20 | 10 / 406 |
muscle | 2% | 4.44 | 16 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0005886 | Cellular component | plasma membrane |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | STK32A |
Protein name | Serine/threonine-protein kinase 32A (EC 2.7.11.1) (Yet another novel kinase 1) Serine/threonine kinase 32A (cDNA, FLJ78841, highly similar to Serine/threonine-protein kinase 32A) Serine/threonine kinase 32A |
Synonyms | YANK1 |
Description | |
Accessions | B7Z9H7 ENST00000397936.8 [Q8WU08-1] ENST00000398523.3 A0A3B3IS85 Q8WU08 ENST00000648628.1 ENST00000626951.2 [Q8WU08-2] |